Literature DB >> 26221304

Relationship between gene mutations and protein expressions of PDGFR α and C-kit in gastrointestinal stromal tumors.

Jun-Yi He1, H X Tong1, Y Zhang1, J Y Wang1, Y B Shao1, J Zhu1, Wei-Qi Lu1.   

Abstract

OBJECTIVE: To investigate the relationship between gene mutations and protein expressions of PDGFR α and C-kit in gastrointestinal stromal tumors (GIST) and its significance in tumorigenesis.
METHODS: Single strand conformation polymorphism-polymerase chain reaction (PCR-SSCP), immunohistochemistry and Western blot were used to detect the gene mutations in PDGFR α and C-kit and their protein expressions in 105 cases of GIST specimens.
RESULTS: In 105 cases of GIST, PDGFR α gene mutation was found in 12 cases (11.4%), which was common in the stomach- derived spindle cell GIST. C-kit gene mutation was found in 58 cases (55.2%), which was common in the small intestine. Mutations of PDGFR α is in 12 cases of GIST were stronger than the C-kit mutations in GIST, normal gastrointestinal tissues and schwannomas. No significant correlation was found between mutations and C-kit protein expression (P>0.05), while the protein expression of PDGFR α was significantly correlated with mutations (P<0.0001).
CONCLUSION: Mutations of PDGFR α and C-kit plays an important role in part of GIST tumorigenesis. Mutation sites were related with original sites and histological types. Most protein expressions were closely related to their gene mutations in GIST.

Entities:  

Keywords:  C-kit; GIST; PDGFR α; SSCP; Western blot; gene mutation

Year:  2015        PMID: 26221304      PMCID: PMC4509249     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

Review 1.  Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

Authors:  Michael C Heinrich; Brian P Rubin; B Jack Longley; Jonathan A Fletcher
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

2.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

Authors:  L G Kindblom; H E Remotti; F Aldenborg; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

Authors:  Johanna Andersson; Harri Sihto; Jeanne M Meis-Kindblom; Heikki Joensuu; Nina Nupponen; Lars-Gunnar Kindblom
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

Review 4.  PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

Authors:  Christopher L Corless; Arin Schroeder; Diana Griffith; Ajia Town; Laura McGreevey; Patina Harrell; Sharon Shiraga; Troy Bainbridge; Jason Morich; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2005-05-31       Impact factor: 44.544

5.  Gastrointestinal stromal tumor (GIST) in southern Taiwan: a clinicopathologic study of 93 resected cases.

Authors:  Chien-Feng Li; Shih-Sung Chuang; Chin-Li Lu; Ching-Nan Lin
Journal:  Pathol Res Pract       Date:  2005       Impact factor: 3.250

6.  Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.

Authors:  C A Moskaluk; Q Tian; C R Marshall; C A Rumpel; D W Franquemont; H F Frierson
Journal:  Oncogene       Date:  1999-03-11       Impact factor: 9.867

7.  Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.

Authors:  Maria Debiec-Rychter; Jan Cools; Herlinde Dumez; Raf Sciot; Michel Stul; Nicole Mentens; Hilde Vranckx; Bartosz Wasag; Hans Prenen; Johannes Roesel; Anne Hagemeijer; Allan Van Oosterom; Peter Marynen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

8.  PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

9.  KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.

Authors:  Harri Sihto; Maarit Sarlomo-Rikala; Olli Tynninen; Minna Tanner; Leif C Andersson; Kaarle Franssila; Nina N Nupponen; Heikki Joensuu
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544

10.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.